Michelle Vendel
About Michelle Vendel
Michelle Vendel is a Principal Scientist at Bristol Myers Squibb in San Diego, California, with over 20 years of experience in the biopharmaceutical industry.
Company
Michelle Vendel is currently working at Bristol Myers Squibb in San Diego, California, United States. She holds the position of Principal Scientist, reflecting her significant experience in the biopharmaceutical industry.
Title
Michelle Vendel holds the title of Principal Scientist at Bristol Myers Squibb. This role follows her previous positions within the company, most recently as Scientist II in 2020.
Education and Expertise
Michelle Vendel studied Biochemistry at The University of Glasgow, where she earned a Master of Science degree. Her expertise spans over two decades in the biopharmaceutical industry, with a strong background in molecular biology and protein chemistry. This extensive knowledge base was developed through roles at leading pharmaceutical companies such as Pfizer, Biogen, and Genentech.
Professional Background
Michelle Vendel has over 20 years of experience in the biopharmaceutical industry. She has held various roles, including Senior Scientist at Pfizer for 8 years and Senior Associate Scientist at Biogen for 1 year. Her early career included a 6-year tenure as a Research Associate at Genentech. She also worked as Scientist I at Celgene before joining Bristol Myers Squibb.
Significant Contributions
Throughout her career, Michelle Vendel has contributed to multiple drug development projects. At Pfizer, she advanced several key therapies, and at Genentech, she focused on early-stage research in oncology and immunology. During her time at Biogen, she played a pivotal role in developing treatments for neurological disorders.